CA2817211A1 - Hydroxamic acid derivatives and their use in the treatment of bacterial infections - Google Patents

Hydroxamic acid derivatives and their use in the treatment of bacterial infections Download PDF

Info

Publication number
CA2817211A1
CA2817211A1 CA2817211A CA2817211A CA2817211A1 CA 2817211 A1 CA2817211 A1 CA 2817211A1 CA 2817211 A CA2817211 A CA 2817211A CA 2817211 A CA2817211 A CA 2817211A CA 2817211 A1 CA2817211 A1 CA 2817211A1
Authority
CA
Canada
Prior art keywords
hydroxymethyl
buta
diynyl
methyl
hydroxyamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2817211A
Other languages
English (en)
French (fr)
Inventor
Ramesh Kasar
Martin Sheringham Linsell
James Bradley Aggen
Qing LU (Jane)
Dan Wang
Tim CHURCH
Heinz E. Moser
Phillip A. Patten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Achaogen Inc
Original Assignee
Achaogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achaogen Inc filed Critical Achaogen Inc
Publication of CA2817211A1 publication Critical patent/CA2817211A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2817211A 2010-11-10 2011-11-04 Hydroxamic acid derivatives and their use in the treatment of bacterial infections Abandoned CA2817211A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41231110P 2010-11-10 2010-11-10
US61/412,311 2010-11-10
PCT/US2011/059280 WO2012154204A1 (en) 2010-11-10 2011-11-04 Hydroxamic acid derivatives and their use in the treatment of bacterial infections

Publications (1)

Publication Number Publication Date
CA2817211A1 true CA2817211A1 (en) 2012-11-15

Family

ID=46317476

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2817211A Abandoned CA2817211A1 (en) 2010-11-10 2011-11-04 Hydroxamic acid derivatives and their use in the treatment of bacterial infections

Country Status (14)

Country Link
EP (1) EP2638006A1 (enExample)
JP (1) JP2014501716A (enExample)
KR (1) KR20140023869A (enExample)
CN (1) CN103298780A (enExample)
AR (1) AR083760A1 (enExample)
AU (1) AU2011367819A1 (enExample)
BR (1) BR112013011693A2 (enExample)
CA (1) CA2817211A1 (enExample)
EA (1) EA201390626A1 (enExample)
IL (1) IL226270A0 (enExample)
MX (1) MX2013005200A (enExample)
SG (1) SG190243A1 (enExample)
TW (1) TW201249786A (enExample)
WO (1) WO2012154204A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008154642A2 (en) 2007-06-12 2008-12-18 Achaogen, Inc. Antibacterial agents
WO2013170030A1 (en) * 2012-05-09 2013-11-14 Achaogen, Inc. Antibacterial agents
WO2013170165A1 (en) 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
TR201807881T4 (tr) 2013-12-19 2018-06-21 Idorsia Pharmaceuticals Ltd Antibakteriyel 1h-ındazol ve 1h-ındol türevleri.
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
US9539305B1 (en) 2014-03-14 2017-01-10 Fleurir Abx Llc Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
JP2017515906A (ja) 2014-05-16 2017-06-15 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ 抗菌性キナゾロン−４（３ｈ）−オン誘導体
KR20170086079A (ko) 2014-11-19 2017-07-25 액테리온 파마슈티칼 리미티드 항균성 벤조티아졸 유도체
EA032138B1 (ru) 2014-12-16 2019-04-30 Новартис Аг СОЕДИНЕНИЯ ИЗОКСАЗОЛГИДРОКСАМИНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LpxC
EP3448375B1 (en) 2016-04-25 2023-09-27 Duke University Benzoylglycine derivatives and methods of making and using same
CA3026356A1 (en) 2016-06-14 2017-12-21 Novartis Ag Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
WO2017223349A1 (en) 2016-06-23 2017-12-28 Achaogen, Inc. Antibacterial agents
CA3090833A1 (en) * 2018-02-10 2019-08-15 Kbp Biosciences Co., Ltd. Compound acting as antibiotics
CN110563611B (zh) * 2019-09-19 2021-02-02 中国医学科学院医药生物技术研究所 一种异羟肟酸类衍生物及其制备方法和应用
CN113957098A (zh) * 2021-09-13 2022-01-21 湖南工业大学 普罗威登斯属细菌菌株在制备二价锰氧化剂中的应用
CN116730870B (zh) * 2023-08-08 2023-10-13 中国医学科学院医药生物技术研究所 异羟肟酸类化合物或其可药用盐、及其用途和制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925659A (en) 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
US6541276B2 (en) 1996-10-28 2003-04-01 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereof
WO2000061134A1 (en) 1999-04-09 2000-10-19 British Biotech Pharmaceuticals Limited Antimicrobial agents
SG2012000667A (en) * 2003-01-08 2015-03-30 Univ Washington Antibacterial agents
DE102006032709A1 (de) 2006-07-14 2008-01-17 BSH Bosch und Siemens Hausgeräte GmbH Luftschallgedämmte Lebensmittelmühle
CN101209974A (zh) * 2006-12-31 2008-07-02 天津药物研究院 异羟肟酸类衍生物及其用途
WO2008154642A2 (en) * 2007-06-12 2008-12-18 Achaogen, Inc. Antibacterial agents
WO2011005355A1 (en) * 2009-05-07 2011-01-13 Achaogen, Inc. Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
PH12012502087A1 (en) * 2010-04-20 2015-04-15 Taisho Pharmaceutical Co Ltd Novel hydroxamic acid derivative

Also Published As

Publication number Publication date
WO2012154204A1 (en) 2012-11-15
EA201390626A1 (ru) 2013-12-30
EP2638006A1 (en) 2013-09-18
AU2011367819A1 (en) 2013-05-02
AR083760A1 (es) 2013-03-20
JP2014501716A (ja) 2014-01-23
MX2013005200A (es) 2013-06-28
KR20140023869A (ko) 2014-02-27
CN103298780A (zh) 2013-09-11
IL226270A0 (en) 2013-07-31
TW201249786A (en) 2012-12-16
SG190243A1 (en) 2013-06-28
BR112013011693A2 (pt) 2016-08-09

Similar Documents

Publication Publication Date Title
CA2817211A1 (en) Hydroxamic acid derivatives and their use in the treatment of bacterial infections
US9701622B2 (en) Antibacterial agents
US10023528B2 (en) Branched 3-phenylpropionic acid derivatives and their use
US9018258B2 (en) Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof
JP5550650B2 (ja) 細菌感染症処置に適用するための有機化合物
JP6138243B2 (ja) 置換ピペリジノアセトアミドおよびその使用
US20190209592A1 (en) Bicyclic aryl sphingosine 1-phosphate analogs
TW201100076A (en) Substituted aminopropionic derivatives as neprilysin inhibitors
BG107229A (bg) Циклопентил-заместени глутарамидни производни като инхибитори на неутрална ендопептидаза
WO2014165075A1 (en) Antibacterial agents
KR19980701869A (ko) 사람 백혈구 엘라스타제 억제제로 유용한 프롤린 유도체
US20150203444A1 (en) Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
AU2004255633B2 (en) Compound having anti-HCV action
CA2584610A1 (en) Novel dicarboxylic acid derivatives
US7767854B2 (en) N-substituted phenylacetamide derivative and pharmaceutical composition containing the same
CA2558249A1 (en) Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
TW202029965A (zh) 作為胺肽酶a抑制劑之新穎胺基膦衍生物
EA010133B1 (ru) Производные формамида, пригодные в качестве адренорецептора
NZ616274B2 (en) Branched 3-phenylpropionic acid derivatives and the use thereof

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20161104